Development of an in vitro PIG-A gene mutation assay in human cells.

about

In vivo pig-a and micronucleus study of the prototypical aneugen vinblastine sulfate.Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk+/- cells and the CD90.2 antigen.

P2860

Q38612050-FA978DC3-3BAE-413A-8EAC-9BC3971E0C29 Q47427835-E41B5F06-5A04-4338-9C93-4D4107A866F5

P2860

Development of an in vitro PIG-A gene mutation assay in human cells.

Item

http://www.wikidata.org/entity/Q38722763

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Development of an in vitro PIG-A gene mutation assay in human cells.

@en

type

Item

label

Development of an in vitro PIG-A gene mutation assay in human cells.

@en

prefLabel

Development of an in vitro PIG-A gene mutation assay in human cells.

@en

P1476

Development of an in vitro PIG-A gene mutation assay in human cells.

@en

P2093

Anthony M Lynch

http://www.w3.org/2001/XMLSchema#string

Benjamin J Rees

http://www.w3.org/2001/XMLSchema#string

Catherine A Thornton

http://www.w3.org/2001/XMLSchema#string

Gareth J Jenkins

http://www.w3.org/2001/XMLSchema#string

George E Johnson

http://www.w3.org/2001/XMLSchema#string

Matthew Tate

http://www.w3.org/2001/XMLSchema#string

Richard M Walmsley

http://www.w3.org/2001/XMLSchema#string

P2860

Advancing human health risk assessment: integrating recent advisory committee recommendations

Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients

The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis

Apoptosis: a review of programmed cell death

Aerolysin--the ins and outs of a model channel-forming toxin.

Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework.

Measuring reproducibility of dose response data for the Pig-a assay using covariate benchmark dose analysis.

Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.

P304

283-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/MUTAGE/GEW059

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28057708

http://www.w3.org/2001/XMLSchema#string

P932

5907909

http://www.w3.org/2001/XMLSchema#string

Development of an in vitro PIG-A gene mutation assay in human cells.

about

P2860

P2860

Development of an in vitro PIG-A gene mutation assay in human cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932